Home 禄 Business 禄 Manufacturing
MSD taps growing demand
MSD China yesterday unveiled a US$120 million plant, set to be the largest facility in Asia-Pacific for its US parent, in Hangzhou as the drug company taps the growing demand in China.
The new plant, located in the Hangzhou Economic & Technological Development Area, has the most up-to-date facilities such as 16 high speed production lines and has an estimated capacity to make 300 million packs annually.
"The new Hangzhou plant marks another milestone for MSD and we're seeking to bring more innovative medicines and vaccines to China," said Pam Cheng, president of MSD China.
MSD has over 90 factories worldwide and the Hangzhou plant will play a key role in the firm's global manufacturing chain.
The new plant will join an integrated, interdependent network of 72 MSD factories that supply medicines and vaccines to more than 140 countries worldwide.
The new plant, located in the Hangzhou Economic & Technological Development Area, has the most up-to-date facilities such as 16 high speed production lines and has an estimated capacity to make 300 million packs annually.
"The new Hangzhou plant marks another milestone for MSD and we're seeking to bring more innovative medicines and vaccines to China," said Pam Cheng, president of MSD China.
MSD has over 90 factories worldwide and the Hangzhou plant will play a key role in the firm's global manufacturing chain.
The new plant will join an integrated, interdependent network of 72 MSD factories that supply medicines and vaccines to more than 140 countries worldwide.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.